Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Antisense And RNAi Therapeutics Market 2021- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease), And By Region, Opportunities And Strategies – Global Forecast To 2030

Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000.00 $2800.00 | Pages : 272 | Published : February 2021 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Antisense & RNAi Therapeutics Market Definition

The antisense and RNAi therapeutics market consists of sales of antisense and RNAi therapeutics by entities (organizations, sole traders, and partnerships) that develop and manufacture antisense and RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various diseases including cancer, infectious diseases, cardiovascular diseases, genetic disorders, respiratory disorders, and neurological disorders.

Two major methods are employed in RNA therapeutics: double stranded RNA-mediated interference (RNAi) and antisense oligonucleotides (ASO). Both these methods differ in composition and modes of action. These antisense oligonucleotides and siRNAs mainly target the ribonucleic acid (RNA), whereas small molecules and biologic drugs primarily target proteins due to their chemical properties and distinct molecular mechanism of action.

Book your 30 minutes free consultation with our research experts

Contact Us

Antisense & RNAi Therapeutics Market Size

The global antisense and RNAi therapeutics market reached a value of nearly $3,677.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 38.2% since 2017.  The market is expected to grow from $3,677.3 million in 2020 to $5,660.6 million in 2025 at a rate of 9.0%. The growth is mainly due to the growing demand for antisense and RNAi therapeutics due to COVID-19 which is expected to drive the demand for antisense and RNAi therapeutics. The market is expected to grow to $8,261.2 million in in 2030 at a CAGR of 7.9%.  

Growth in the historic period resulted from rise in funding, advancement in technologies, and rise in healthcare expenditure, rapid growth in elderly population and economic growth in emerging markets. This growth was restricted by regulatory challenges and delivery challenges.

Going forward, increase in healthcare access, rising prevalence of caner and increasing demand for antisense and RNAi therapeutics due to COVID-19 are expected to drive the market. High costs of tests, rising popularity of competing products and difficulty in manufacturing and transporting antisense and RNAi therapeutics are major factors that could hinder the growth of the antisense and RNAi therapeutics market in the future.

Antisense & RNAi Therapeutics Market Drivers

The key drivers of the antisense & RNAi therapeutics market include:

Increase in Healthcare Access

Access to healthcare services is expected to improve in developing countries, thus supporting the antisense and RNAi therapeutics market. Effective implementation of government health plans is the core reason for the improvement in healthcare access in many developing regions such as India, China and many Latin American countries. Many countries such as Russia and Brazil are focusing on improving their healthcare capabilities which will help drive the antisense and RNAi therapeutics market.

Antisense & RNAi Therapeutics Market Restraints

The key restraints on the antisense & RNAi therapeutics market include:

High Costs of Tests

High costs associated with the antisense and RNAi therapeutics is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. For instance, according to Future Medicine, the price of Onpattro is approximately $450,000 per year. Onpattro (patisaran) is the RNA interference-based drug used for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. Stringent regulations, long product approval process, high development cost, and a comparably small number of patients are few factors leading to the high cost of RNA interference drugs, which is expected to hinder the antisense & RNAi therapeutics’ market growth in upcoming years.

Antisense & RNAi Therapeutics Market Trends

Major trends shaping the antisense & RNAi therapeutics market include the following:

Demand for RNAi Therapeutics in The Treatment Of Orphan Diseases

RNAi therapeutics are being widely used to provide effective treatment for many complex orphan diseases such as acute hepatic porphyria (AHP) and hereditary transthyretin amyloidosis that have limited treatment options. RNAi therapeutic companies are increasingly opting to produce drugs for orphan diseases as people suffering from orphan diseases are often more willing to tolerate drugs with side effects. People suffering from orphan diseases also visit doctors regularly, thus find it acceptable to opt for drugs that have a more involved delivery route. For instance, in 2018, the US and European regulators approved two RNA based drugs for the rare genetic disease hereditary transthyretin (hATTR) amyloidosis, which affects around 50,000 people worldwide. The disease is caused by mutations in the gene that can cause causes a loss of sensation in the lower limbs, feet, and hands. The disease may also cause disturbances in blood pressure, heart rate, and digestion.

Revised FDA Regulations to Facilitate Drug Development

The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, including antisense and RNAi therapeutics thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure safety, purity and potency of biologics can now be obtained from sources other than FDA’s Center for Biologics Evaluation and Research (CBER), or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) which specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics, including antisense and RNAi therapeutics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products.

Opportunities and Recommendations in The Antisense & RNAi Therapeutics Market

Opportunities – The top opportunities in the antisense and RNAi therapeutics market segmented by technology will arise in the antisense RNA segment, which will gain $1,362.3 million of global annual sales by 2025. The top opportunities in the antisense and RNAi therapeutics market segmented by route of administration will arise in the intravenous injections segment, which will gain $962.6 million of global annual sales by 2025. The top opportunities in the antisense and RNAi therapeutics market segmented by indication will arise in the other indications segment, which will gain $ 1,056.1 million of global annual sales by 2025. The antisense and RNAi therapeutics’ market size will gain the most in the USA at $737.1 million.

Recommendations – To take advantage of the opportunities, The Business Research Company recommends the antisense & RNAi therapeutics to focus on research and development for RNAi therapeutics to treat orphan diseases, expand product portfolios through collaborations, offer skimmed pricing, expand in emerging markets, promote their drugs through physicians and NGOs, increase visibility through websites and target people suffering from various diseases.

The countries covered in Antisense And RNAi Therapeutics Market are China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Antisense & RNAi Therapeutics Market Segmentation

The antisense and RNAi therapeutics market is segmented by technology, by route of administration, by indication and by geography.
Segmentation by Technology
The report provides the following market segmentation by technology.
The antisense and RNAi therapeutics market is segmented by technology into
    • a) By RNA Interference
    • b) Antisense RNA
The antisense RNA market was the largest segment of the antisense and RNAi therapeutics market by technology, accounting for 94.9% of the total market in 2020. Going forward, RNA interference segment is expected to be the fastest growing segment in the antisense and RNAi therapeutics market, at a CAGR of 20.1%.
Segmentation by Route of Administration
The antisense and RNAi therapeutics market is also segmented by route of administration into:
    • a) Intravenous injections
    • b) Intra Dermal injunctions
    • c) Other delivery methods
The intravenous injections market was the largest segment of the antisense and RNAi therapeutics market by route of administration, accounting for 93.8% of the total market in 2020. Going forward, the intra-dermal segment is expected to be the fastest growing segment in the antisense and RNAi therapeutics market, at a CAGR of 26.9%.
Segmentation by Indication
The antisense and RNAi therapeutics market is also segmented by indication into:
    • a) Oncology
    • b) Cardiovascular device
    • c) Respiratory disorders
    • d) Neurological disorders
    • e) Infectious disease
    • f) Other diseases
The neurological disorders market was the largest segment of the antisense and RNAi therapeutics market by indication, accounting for 89.5% of the total market in 2020. Going forward, the infectious diseases segment is expected to be the fastest growing segment in the antisense and RNAi therapeutics market, at a CAGR of 88.4%.
Segmentation by Geography
The report provides the following segmentation by geography
    • o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      • o North America
      • • United States of America
      o South America
      • • Brazil
      o Western Europe
      • • UK
      • • Germany
      • • France
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
Western Europe was the largest region in the global antisense and RNAi therapeutics market, accounting for 52.0% of the total in 2020. It was followed by the North America, Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the antisense and RNAi therapeutics market will be Middle East and Africa, where growth will be at CAGRs of 22.5% and 17.9% respectively. These will be followed by Asia Pacific and South America, where the markets are expected to register CAGRs of 15.8% and 15.0% respectively.

Antisense & RNAi Therapeutics Market Competitive Landscape

Major Competitors In The Global Antisense And Rnai Therapeutics Market Are:

  • Biogen Inc.
  • Ionis Pharmaceuticals, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • Moderna, Inc.

    • Other Competitors In The Global Antisense And Rnai Therapeutics Market Include:

  • Sanofi S.A.
  • Dicerna Pharmaceuticals, Inc.
  • Arbutus Biopharma Corporation
  • Acuitas Therapeutics
  • Adhera Therapeutics, Inc.
  • EdiGene Inc.
  • Sirnaomics Inc.
  • Shanghai Junshi Biosciences Co. Ltd.
  • Suzhou Ribo Life Science Co. Ltd
  • Biocon Limited
  • GlaxoSmithKline Plc
  • AstraZeneca
  • Benitec Biopharma Limited
  • Quark Pharmaceuticals
  • Silence Therapeutics
  • Dynacure,
  • CN Bio Innovations
  • Sarepta Therapeutics
  • Mallinckrodt
  • Regeneron Pharmaceuticals, Inc.
  • Alcyone Lifesciences, Inc.
  • Bio-Path Holdings Inc
  • Enzon Pharmaceuticals Inc
  • Celnova Pharma
  • Pfizer
  • Novartis AG
  • Calando Pharmaceuticals
  • Taiba Pharma
  • Gen Ilaç ve Saglik Ürünleri A.S.
  • Egypt Otsuka Pharmaceutical

      • Table Of Contents

      1. Antisense & RNAi Therapeutics Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Technology

      6.3. Segmentation By Route of Administration

      6.4. Segmentation By Indication

      7. Antisense & RNAi Therapeutics Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Technology

      7.2.1. RNA Interference

      7.2.2. Antisense RNA

      7.3. Segmentation By Route Of Administration

      7.3.1. Intravenous Injections

      7.3.2. Intra-Dermal Injections

      7.3.3. Other Delivery Methods

      7.4. Segmentation By Indication

      7.4.1. Oncology

      7.4.2. Cardiovascular Diseases

      7.4.3. Respiratory Disorders

      7.4.4. Neurological Disorders

      7.4.5. Infectious Diseases

      7.4.6. Other Diseases

      8. Antisense & RNAi Therapeutics Market Trends And Strategies

      8.1. Demand For RNAi Therapeutics In The Treatment Of Orphan Diseases

      8.2. Revised FDA Regulations To Facilitate Drug Development

      8.3. Growing Demand For Nanoparticles For Drug Delivery

      8.4. Strategic Collaborations And Partnerships

      9. COVID-19 Impact On The Antisense & RNAi Therapeutics Market

      9.1. Using Antisense And RNAi Therapeutics In COVID-19 Vaccines

      9.2. How Antisense And RNAi Companies Are Tackling The Virus

      10. Global Antisense & RNAi Therapeutics Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2017 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2017-2020

      10.2.2. Restraints On The Market 2017-2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020-2025

      10.3.2. Restraints On The Market 2020-2025

      11. Global Antisense & RNAi Therapeutics Market Segmentation

      11.1. Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. Antisense RNA

      11.1.2. RNA Interference

      11.2. Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Intravenous Injections

      11.2.2. Intra-dermal Injections

      11.2.3. Others

      11.3. Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      11.3.1. Neurological Disorders

      11.3.2. Cardiovascular Diseases (CVDs)

      11.3.3. Infectious Diseases

      11.3.4. Oncology

      11.3.5. Respiratory Disorders

      11.3.6. Other Indications

      12. Antisense & RNAi Therapeutics Market, Regional And Country Analysis

      12.1. Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Antisense & RNAi Therapeutics Market

      13.1. Asia-Pacific Antisense & RNAi Therapeutics Market Overview

      13.1.1. Region Information

      13.1.2. Impact of COVID-19

      13.1.3. Market Information

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      13.3. Asia-Pacific Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific Antisense & RNAi Therapeutics Market: Country Analysis

      13.7. China Antisense & RNAi Therapeutics Market

      13.8. China Antisense & RNAi Therapeutics Market Overview

      13.8.1. Country Information

      13.8.2. Impact of COVID-19

      13.8.3. Market Information

      13.8.4. Background Information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Corporate Tax Structure

      13.8.10. Investments

      13.8.11. Major Companies

      13.9. China Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      13.10. China Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Antisense & RNAi Therapeutics Market

      13.14. India Antisense & RNAi Therapeutics Market Overview

      13.14.1. Country Information

      13.14.2. Impact of COVID-19

      13.14.3. Market Information

      13.14.4. Background Information

      13.14.5. Government Initiatives

      13.14.6. Regulations

      13.14.7. Regulatory Bodies

      13.14.8. Major Associations

      13.14.9. Corporate Tax Structure

      13.14.10. Investments

      13.14.11. Major Companies

      13.15. India Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.16. India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Antisense & RNAi Therapeutics Market

      13.19. Japan Antisense & RNAi Therapeutics Market Overview

      13.19.1. Country Information

      13.19.2. Impact of COVID-19

      13.19.3. Market Information

      13.19.4. Background Information

      13.19.5. Government Initiatives

      13.19.6. Regulations

      13.19.7. Regulatory Bodies

      13.19.8. Major Associations

      13.19.9. Corporate Tax Structure

      13.19.10. Investments

      13.19.11. Major Companies

      13.20. Japan Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      13.21. Japan Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.22. Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.24. Australia Antisense & RNAi Therapeutics Market

      13.25. Australia Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      13.26. Australia Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.27. Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.29. Indonesia Antisense & RNAi Therapeutics Market

      13.30. Indonesia Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.31. Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Antisense & RNAi Therapeutics Market

      13.34. South Korea Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      13.35. South Korea Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.36. South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Antisense & RNAi Therapeutics Market

      14.1. Western Europe Antisense & RNAi Therapeutics Market Overview

      14.1.1. Region Information

      14.1.2. Impact Of COVID-19

      14.1.3. Market Information

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      14.3. Western Europe Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Antisense & RNAi Therapeutics Market: Country Analysis

      14.7. UK Antisense & RNAi Therapeutics Market

      14.8. UK Antisense & RNAi Therapeutics Market Overview

      14.8.1. Country Information

      14.8.2. Impact Of COVID-19

      14.8.3. Market Information

      14.8.4. Background Information

      14.8.5. Government Initiatives

      14.8.6. Regulations

      14.8.7. Regulatory Bodies

      14.8.8. Major Associations

      14.8.9. Taxes Levied

      14.8.10. Corporate Tax Structure

      14.8.11. Investments

      14.8.12. Major Companies

      14.9. UK Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      14.10. UK Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.11. UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.13. Germany Antisense & RNAi Therapeutics Market

      14.14. Germany Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      14.15. Germany Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.16. Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.18. France Antisense & RNAi Therapeutics Market

      14.19. France Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      14.20. France Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.21. France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      14.22. France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Antisense & RNAi Therapeutics Market

      15.1. Eastern Europe Antisense & RNAi Therapeutics Market Overview

      15.1.1. Region Information

      15.1.2. Impact Of COVID-19

      15.1.3. Market Information

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Taxes Levied

      15.1.10. Corporate Tax Structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      15.3. Eastern Europe Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Antisense & RNAi Therapeutics Market: Country Analysis

      15.7. Russia Antisense & RNAi Therapeutics Market

      15.8. Russia Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      15.9. Russia Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Antisense & RNAi Therapeutics Market

      16.1. North America Antisense & RNAi Therapeutics Market Overview

      16.1.1. Region Information

      16.1.2. Impact Of COVID-19

      16.1.3. Market Information

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Major Associations

      16.1.9. Taxes Levied

      16.1.10. Corporate Tax Structure

      16.1.11. Investments

      16.1.12. Major Companies

      16.2. North America Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      16.3. North America Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Antisense & RNAi Therapeutics Market: Country Analysis

      16.7. USA Antisense & RNAi Therapeutics Market

      16.8. USA Antisense & RNAi Therapeutics Market Overview

      16.8.1. Country Information

      16.8.2. Impact Of COVID-19

      16.8.3. Market Information

      16.8.4. Background Information

      16.8.5. Government Initiatives

      16.8.6. Regulations

      16.8.7. Regulatory Bodies

      16.8.8. Major Associations

      16.8.9. Taxes Levied

      16.8.10. Corporate Tax Structure

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      16.10. USA Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Antisense & RNAi Therapeutics Market

      17.1. South America Antisense & RNAi Therapeutics Market Overview

      17.1.1. Region Information

      17.1.2. Impact Of COVID-19

      17.1.3. Market Information

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies,

      17.2. South America Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      17.3. South America Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Antisense & RNAi Therapeutics Market: Country Analysis

      17.7. Brazil Antisense & RNAi Therapeutics Market

      17.8. Brazil Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      17.9. Brazil Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Antisense & RNAi Therapeutics Market

      18.1. Middle East Antisense & RNAi Therapeutics Market Overview

      18.1.1. Region Information

      18.1.2. Impact Of COVID-19

      18.1.3. Market Information

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulatory Bodies

      18.1.7. Regulations

      18.1.8. Major Associations

      18.1.9. Taxes Levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Middle East Antisense & RNAi Therapeutics Market, Historic Market Growth, 2017 – 2020, Value ($ Million)

      18.3. Middle East Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Antisense & RNAi Therapeutics Market

      19.1. Africa Antisense & RNAi Therapeutics Market Overview

      19.1.1. Region Information

      19.1.2. Impact Of COVID-19

      19.1.3. Market Information

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Antisense & RNAi Therapeutics Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.3. Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      19.4. Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Antisense & RNAi Therapeutics Market Competitive Landscape

      20.1. Company Profiles

      20.2. Biogen Inc.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Ionis Pharmaceuticals, Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Alnylam Pharmaceuticals, Inc.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Arrowhead Pharmaceuticals, Inc.

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Moderna, Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      20.7. Sanofi S.A.

      20.7.1. Company Overview

      20.7.2. Products And Services

      20.7.3. Business Strategy

      20.7.4. Financial overview

      20.8. Dicerna Pharmaceuticals, Inc.

      20.8.1. Company Overview

      20.8.2. Products And Services

      20.8.3. Business Strategy

      20.8.4. Financial overview

      21. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market

      21.1. Secarna Pharmaceuticals Acquired Lipigon Pharmaceuticals

      21.2. Astellas Pharma Acquired Gene Therapy Firm Audentes

      21.3. Novartis International AG Acquired The Medicines Company

      21.4. NeuBase Therapeutics Merged With Ohr Pharmaceutical

      21.5. Novartis Acquired AveXis

      22. Antisense & RNAi Therapeutics Market Opportunities And Strategies

      22.1. Global Antisense & RNAi Therapeutics Market In 2025 – Countries Offering Most New Opportunities

      22.2. Global Antisense & RNAi Therapeutics Market In 2025 – Segments Offering Most New Opportunities

      22.3. Global Antisense & RNAi Therapeutics Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Antisense & RNAi Therapeutics Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Price

      23.2.3. Place

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 2: Global Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 4: Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 6: Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 8: Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 10: Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 12: Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia-Pacific Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 14: Asia Pacific Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 15: Asia-Pacific Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 16: Asia-Pacific Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 17: Asia-Pacific Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 18: Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 19: Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 20: Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 21: Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 22: China Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
    • Table 23: China Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
    • Table 24: China Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
    • Table 25: China Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 26: China Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 27: China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 28: China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 29: China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 30: China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 31: India Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
    • Table 32: India Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
    • Table 33: India Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
    • Table 34: India Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 35: India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 36: India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 37: India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 38: India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 39: Japan Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
    • Table 40: Japan Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
    • Table 41: Japan Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
    • Table 42: Japan Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 43: Japan Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 44: Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 45: Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 46: Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 47: Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 48: Australia Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 49: Australia Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 50: Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 51: Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 52: Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 53: Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 54: Indonesia Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 55: Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 56: Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 57: Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 58: Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 59: South Korea Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 60: South Korea Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 61: South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 62: South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 63: South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 64: South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 65: Western Europe Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country2015-2020, $
    • Table 66: Western Europe Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 67: Western Europe Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 68: Western Europe Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 69: Western Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 70: Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 71: Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 72: Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 73: Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 74: UK Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
    • Table 75: UK Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
    • Table 76: UK Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
    • Table 77: UK Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 78: UK Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 79: UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 80: UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 81: UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 82: UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 83: Germany Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 84: Germany Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 85: Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 86: Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 87: Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 88: Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 89: France Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 90: France Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 91: France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 92: France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 93: France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 94: France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 95: Eastern Europe Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 96: Eastern Europe Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 97: Eastern Europe Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 98: Eastern Europe Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 99: Eastern Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 100: Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 101: Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 102: Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 103: Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 104: Russia Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 105: Russia Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 106: Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 107: Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 108: Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 109: Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 110: North America Antisense & RNAi Therapeutics Market, GDP Per Capita, BY Country, 2015-2020, $
    • Table 111: North America Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 112: North America Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 113: North America Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 114: North America Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 115: North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 116: North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 117: North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 118: North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 119: USA Antisense & RNAi Therapeutics Market, GDP Per Capita, 2015-2020, $
    • Table 120: USA Antisense & RNAi Therapeutics Market, Population By Age Group, 2015-2023, Thousands
    • Table 121: USA Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, 2015-2025, $ Billion
    • Table 122: USA Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 123: USA Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 124: USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 125: USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 126: USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 127: USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 128: South America Antisense & RNAi Therapeutics Market, GDP Per Capita, BY Country, 2015-2020, $
    • Table 129: South America Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 130: South America Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 131: South America Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 132: South America Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 133: South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 134: South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 135: South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 136: South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 137: Brazil Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 138: Brazil Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 139: Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 140: Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 141: Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 142: Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 143: Middle East Antisense & RNAi Therapeutics Market, GDP Per Capita, BY Country, 2015-2020, $
    • Table 144: Middle East Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 145: Middle East Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 146: Middle East Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Table 147: Middle East Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 148: Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 149: Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 150: Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 151: Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 152: Africa Antisense & RNAi Therapeutics Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 153: Africa Antisense & RNAi Therapeutics Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 154: Africa Antisense & RNAi Therapeutics Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 155: Africa Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 156: Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 157: Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 158: Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Table 159: Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, $ Million
    • Table 160: Global Antisense & RNAi Therapeutics Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
    • Table 161: Biogen Inc. – Financial Performance, 2015 – 2019, $ Million
    • Table 162: Ionis Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Table 163: Alnylam Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Table 164: Arrowhead Pharmaceuticals, Inc.  –  Financial Performance, 2016 – 2020, $ Million
    • Table 165: Moderna, Inc. – Financial Performance, 2016 – 2019, $ Million
    • Table 166: Sanofi S.A.  –  Financial Performance, 2015 – 2019, $ Million
    • Table 167: Dicerna Pharmaceuticals, Inc.  –  Financial Performance, 2015 – 2019, $ Million
    • Table 168: Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 169: Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
    • Table 170: Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), Segmentation By Route of Administration, 2020 – 2025
    • Table 171: Global Antisense & RNAi Therapeutics Market Size Gain ($ Million), Segmentation By Indication, 2020 – 2025

    List Of Figures

      Figure 1: Global Antisense & RNAi Therapeutics Market Segmentation By Technology
    • Figure 2: Global Antisense & RNAi Therapeutics Market Segmentation By Route of Administration
    • Figure 3: Global Antisense & RNAi Therapeutics Market Segmentation By Indication
    • Figure 4: Global Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 5: Global Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 7: Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 8: Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 9: Global Antisense & RNAi Therapeutics Market, By Region, Historic and Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 10: Global Antisense & RNAi Therapeutics Market, By Country, Historic and Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 12: Asia-Pacific Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 15: China Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 16: China Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 18: China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 19: India Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 20: India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 21: India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 22: Japan Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 23: Japan Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 24: Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 25: Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 26: Australia Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 27: Australia Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 28: Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 29: Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 30: Indonesia Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 32: Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 33: South Korea Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 34: South Korea Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 35: South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 36: South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 37: Western Europe Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 38: Western Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 40: Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 41: UK Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 42: UK Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 43: UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 44: UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 45: Germany Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 46: Germany Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 47: Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 48: Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 49: France Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 50: France Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 51: France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 52: France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 53: Eastern Europe Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 54: Eastern Europe Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 55: Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 56: Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 57: Russia Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 58: Russia Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 59: Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 60: Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 61: North America Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 62: North America Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 64: North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 65: USA Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 66: USA Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 67: USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 68: USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 69: South America Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 70: South America Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 72: South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 73: Brazil Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 74: Brazil Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 75: Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 76: Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 77: Middle East Antisense & RNAi Therapeutics Market, Historic, 2017 – 2020, $ Million
    • Figure 78: Middle East Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 79: Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 80: Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 81: Africa Antisense & RNAi Therapeutics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 82: Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 83: Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic And Forecast, 2017 – 2020, 2025F, 2030F, %
    • Figure 84: Global Antisense & RNAi Therapeutics Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
    • Figure 85: Biogen Inc. – Financial Performance, 2015 – 2019, $ Million
    • Figure 86: Ionis Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Figure 87: Alnylam Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Figure 88: Arrowhead Pharmaceuticals, Inc. – Financial Performance, 2016 – 2020, $ Million
    • Figure 89: Moderna, Inc. –  Financial Performance, 2016 – 2019,$ Million
    • Figure 90: Sanofi S.A. – Financial Performance, 2015 – 2019, $ Million
    • Figure 91: Dicerna Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million

    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

    Read More

    Global Gene Therapy Market 2022 – Market Opportunities And Strategies

    Read More

    The Microbiome Market Share, Market Size, And Growth Rate 2022

    Read More

    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

    Read More

    Transplant Diagnostics Global Market Report 2024 – By Type (Reagent & Consumables, Instrument, Software & Services), By Transplant Type (Solid Organ, Stem Cell), By Organ (Kidney, Liver, Heart, Lung, Pancreas), By Technology (Non Molecular Assay, Molecular Assay), By End User (Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Bioinformatics Global Market Report 2024 – By Products and Services (Knowledge Management Tools, Data Analysis Platforms, Services), By Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, Other Applications), By End Users (Pharmaceutics, Animal Study, Agriculture, Forensic Science, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024 – By Product (Instruments, Reagents, Consumables), By Instruments (Standard PCR, RT-PCR, Digital PCR), By End User (Pharmaceutical and biotechnology industries, Clinical Diagnostics labs and hospitals, Academics and research organization) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Gene Editing Global Market Report 2024 – By Technology (CRISPR, TALEN, ZFN), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Pharma Microbiology Testing Kits Global Market Report 2024 – By Product (Consumables, Equipment), By Test (Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests), By End User (Hospitals & Diagnostic Centers, Custom Lab Service Providers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Viral Vectors And Plasmid DNA Global Market Report 2024 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Microbiology Diagnostic Devices And Equipment Global Market Report 2024 – By Type (Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables), By Reagents (Pathogen-Specific Kits, General Reagents), By End-User (Diagnostic Laboratories, Hospitals, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Sequencing Market - By Type (Next Generation Sequencing, Third Generation Sequencing, Sanger Sequencing, Global Sequencing), By Products And Services (Consumables, Sequencing Services, Instruments and Software, Global Sequencing) And By Region, Opportunities And Strategies – Global Forecast To 2023

    View Report

    Frequently Asked Questions

    What is the definition of the antisense & rnai therapeutics market?

    The antisense & rnai therapeutics market consists of sales of antisense & RNAi therapeutics products and related services by entities that develop antisense & RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma. In addition to this, antisense & RNAi therapeutics finds its application in curing cancer, infectious diseases, cardiovascular diseases, and genetic disorders. request a sample here

    How will the antisense & rnai therapeutics market drivers and restraints affect antisense & rnai therapeutics market dynamics? What forces will shape the antisense & rnai therapeutics industry going forward?

    The antisense & rnai therapeutics market growth is aided by rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases. However, some antisense & RNAi therapeutics market restraints include high cost of RNA interference-based drugs request a sample here

    What is the forecast market size of the antisense & rnai therapeutics market?

    The antisense & rnai therapeutics market forecast is expected to reach $1.79 billion in 2025 at a compound annual growth rate of 11%. request a sample here

    How is the antisense & rnai therapeutics market segmented?

    The global antisense & RNAi therapeutics market is segmented - 1) By Technology: RNA Interference, Antisense RNA
    2) By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
    3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other     request a sample here

    Which region has largest share, and what is the market size and growth by geography according to the antisense & rnai therapeutics global market report?

    For more detail on this, request a sample here.

    Who are the key players of the global antisense & rnai therapeutics market?

    Top competitors in the antisense & rnai therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A, Acuitas Therapeutics, Antisens request a sample here.

    What are the key trends in the global antisense & rnai therapeutics market?

    Major trends influencing the antisense & rnai therapeutics market include undertaking strategic initiatives such as collaborations and partnerships request a sample here.

    What are the major opportunities in the antisense & rnai therapeutics market and the approaches companies can take to take advantage of them?

    For detail on the future and current opportunities in the global antisense & rnai therapeutics market, request a sample here.

    How does the antisense & rnai therapeutics market relate to the overall economy and other similar markets?

    request a sample here.

    request a sample here.

    request a sample here.